Asthma Risk Increased for Premenopausal Women Using Oral Contraceptives
Oral contraceptive use in women of reproductive age may increase the risk for lifetime asthma.
Oral contraceptive use in women of reproductive age may increase the risk for lifetime asthma.
Researchers suggest the combined effects of adrenarche and menarche may play a role in the relationship
Results from the largest prospective study of rituximab use in patients with relapsing ANCA-associated vasculitis show that 91.2% of participants achieved remission.